Position in VRCA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,608,980
-$132,197 QoQ
Shares Held
426,304
-17.7% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#5
of 43 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRCA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,521,563,900 across 51 Biotechnology names. VRCA ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in VRCA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,608,980 | 426,304 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,741,177 | 518,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,298,266 | 1,118,925 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,754,921 | 639,193 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,707,112 | 8,881,344 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,786,790 | 8,567,400 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,244,700 | 8,921,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||